Table 1.
Patient and Treatment Characteristics (N=125)
| Characteristic | No. of Patients (%) |
|---|---|
| Disease | |
| Primary NSCLC | 91 |
| Recurrent NSCLC | 12 |
| Lung Metastasis | 22 |
| Median age at diagnosis, years (range) | 76 (32–95) |
| Sex | |
| Male | 62 |
| Female | 63 |
| Dose | |
| 60 Gy in 3 fx (BED10= 180) | 4 |
| 54 Gy in 3 fx (BED10= 151.2) | 9 |
| 48 Gy in 4 fx (BED10= 105.6) | 21 |
| 36 Gy in 2 fx (BED10= 100.8) | 1 |
| 50 Gy in 5 fx (BED10= 100) | 14 |
| 44 Gy in 4 fx (BED10= 92.4) | 1 |
| 45 Gy in 5 fx (BED10= 85.5) | 56 |
| 40 Gy in 4 fx (BED10= 80) | 2 |
| 36 Gy in 3 fx (BED10= 79.2) | 1 |
| 40 Gy in 5 fx (BED10= 72) | 6 |
| 30 Gy in 5 fx (BED10= 48) | 7 |
| Other | 3 |
| Median PTV size, cm3 (range) | 63.0 (17.3–401.7) |
| Median GTV size, cm3 (range) | 13.1 (0.6–195.4) |
Abbreviations: BED10, Biologically equivalent dose for α/β = 10; PTV, planning treatment volume; GTV, gross tumor volume; Gy, gray; fx, fraction.